Veradermics MANE
NYSE MANE
$138.78 +0.29 (+0.21%)
As of: Oct 23, 2026 · 3:59 PM EDT

Veradermics (MANE) Profit After Tax (2025 - 2026)

Updated

Veradermics (MANE) reported Profit After Tax of -$23.5 million for Q2 2026, compared with -$15.65 million a year earlier.

Analysis

Veradermics (MANE) Profit After Tax (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Veradermics' Profit After Tax came in at -$78.78 million; for FY2025, it was -$70 million.

  • By year, Profit After Tax came in at -$26.49 million in FY2024.
  • Five-year quarterly Profit After Tax spans a low of -$27.23 million in Q1 2026 and a high of -$12.4 million in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 210.00 Mn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 3.62 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 2.51 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -10.50 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -246.00 Mn
10 Veradermics 5.64 Bn 4.24 Bn - -23.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -23.50 Mn
Mar 31, 2026 -27.23 Mn
Jun 30, 2025 -15.65 Mn
Mar 31, 2025 -12.40 Mn
API Access

Veradermics Profit After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=MANE&period=max&api_key=YOUR_API_KEY